Abstract P1-01-10: A phase 3, multicenter, self-controlled, non-inferiority trial comparing mitoxantrone hydrochloride injection for tracing versus technetium-99m in the detection of axillary sentinel nodes in patients with early-stage breast cancer

医学 米托蒽醌 前哨淋巴结 乳腺癌 淋巴 淋巴结 内科学 泌尿科 外科 核医学 肿瘤科 癌症 病理 化疗
作者
Benlong Yang,Dechuang Jiao,Jiajian Chen,Chunjian Wang,Lidan Jin,Wenhe Zhao,Xueqiang Gao,Haibo Wang,Jun Li,Haidong Zhao,Di Wu,Zhiming Fan,Shujun Wang,Zhenzhen Liu,Yongsheng Wang,Jiong Wu
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (4_Supplement): P1-01
标识
DOI:10.1158/1538-7445.sabcs21-p1-01-10
摘要

Abstract Aim:Mitoxantrone is an antineoplastic antibiotic used in the treatment of acute leukemia, lymphoma, prostate and breast cancer. Mitoxantrone Hydrochloride Injection for tracing has a high degree of lymph node tropism by changing the dosage form, which penetrates into lymphatic capillaries through the interstitial space and enriches regional lymph nodes through the gland to stain the lymph nodes blue to achieve lymph node tracing effect. This study is aim to evaluate the efficacy and safety of Mitoxantrone Hydrochloride injection(MHI) for tracing sentinel lymph nodes in patients with early-stage breast cancer.Materials & methods: This study was a phase 3, multicenter, self-controlled, non-inferiority trial designed to assess the efficacy and safety of sentinel lymph node tracing with the investigational drug in patients with early-stage breast cancer. All subjects received MHI combined with Technetium-99m(99mTc-Sc), prior to SLNB. The sentinel node identification rate was compared between MHI and 99mTc-Sc to evaluate non-inferiority and concordance. Results: Data were collected from 381 patients in 6 centers all across China. The SLN detection rate was 96.9% (369/381) when using MHI and 97.4% (371/381) when using the standard technique(Table 1). There was no significant difference in the success rate of SLN detection between the two groups(P > 0.05). Since the lower limit of 95% confidence interval was greater than or equal to -5%, the success rate of SLN detection of MHI was non-inferior to that of 99mTc-Sc. In the combination group, 380 cases (99.5%) were successfully detected with SLN. 202 nodes (13.1%) were detected by the MHI but not by the 99mTc-Sc, and 222 nodes (14.4%) were detected by the 99mTc-Sc but not by the MHI(Table 2). All adverse events recovered within one month after intervention.Conclusion: This prospective, multicenter study has shown the Mitoxantrone Hydrochloride injection for tracing to be non-inferior to the standard technique (99mTc-Sc) for breast SLNB. The Mitoxantrone Hydrochloride injection for tracing can be used alone or combined with radioactive material.Key words:Mitoxantrone Hydrochloride injection(MHI), Tracing, Technetium-99m(99mTc-Sc), sentinel lymph node (SLN), Early-Stage Breast Cancer. Attachments: Table 1.SLN detection rate - comparing the Mitoxantrone Hydrochloride Injection and 99mTc-Sc for TracingSLN detection rates [n (%)]Mitoxantrone Hydrochloride Injection for TracingTotalAt least one node detectedNo nodes detected99mTc-ScPositive361 (94.8%)10 (2.6%)371 (97.4%)Negative8 (2.1%)2 (0.5%)10 (2.6%)Total369 (96.9%)12 (3.1%)381(100%) Table 2.Detected nodes-comparing the Mitoxantrone Hydrochloride Injection and 99mTc-Sc for TracingPer node detection rates [n (%)]Mitoxantrone Hydrochloride Injection for TracingTotalPositiveNegative99mTc-ScPositive869 (56.3%)222 (14.4%)1091 (70.7%)Negative202 (13.1%)251 (16.3%)453 (29.3%)Total1071 (69.4%)473 (30.6%)1544 (100%) Citation Format: Benlong Yang, Dechuang Jiao, Jiajian Chen, Chunjian Wang, Lidan Jin, Wenhe Zhao, Xueqiang Gao, Haibo Wang, Jun Li, Haidong Zhao, Di Wu, Zhiming Fan, Shujun Wang, Zhenzhen Liu, Yongsheng Wang, Jiong Wu. A phase 3, multicenter, self-controlled, non-inferiority trial comparing mitoxantrone hydrochloride injection for tracing versus technetium-99m in the detection of axillary sentinel nodes in patients with early-stage breast cancer [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P1-01-10.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彤航完成签到,获得积分10
刚刚
玲玲发布了新的文献求助10
刚刚
高高完成签到,获得积分10
刚刚
NumbCn完成签到,获得积分10
1秒前
virbaroque完成签到,获得积分10
1秒前
郑敏阳完成签到,获得积分10
1秒前
无极微光的应助被千日粉采纳,获得20
1秒前
憨豆完成签到 ,获得积分10
2秒前
zz发布了新的文献求助10
3秒前
柠柠完成签到,获得积分10
3秒前
4秒前
4秒前
4秒前
4秒前
wl完成签到,获得积分10
4秒前
wxyZ发布了新的文献求助10
4秒前
她不吃西瓜完成签到,获得积分10
4秒前
tkxfy完成签到,获得积分10
4秒前
Owen的应助被myz采纳,获得10
4秒前
鲸落小小的应助被Wan采纳,获得30
4秒前
活泼的三娘完成签到 ,获得积分10
4秒前
中道完成签到,获得积分10
5秒前
ssssssion完成签到,获得积分10
6秒前
Kaitlyn完成签到,获得积分10
6秒前
gzr完成签到 ,获得积分10
7秒前
甘霖发布了新的文献求助10
7秒前
8秒前
充电宝的应助被spring采纳,获得10
8秒前
8秒前
从嘉发布了新的文献求助10
8秒前
高贵雅阳完成签到,获得积分10
8秒前
lajdoa完成签到,获得积分10
9秒前
duke完成签到 ,获得积分10
9秒前
阿辽发布了新的文献求助10
9秒前
无花果的应助被玲玲采纳,获得10
9秒前
10秒前
夏待秋autumn完成签到,获得积分10
10秒前
10秒前
领导范儿的应助被霁月采纳,获得10
10秒前
zhangyupei完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253